CRIS, Curis (formerly CBMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI)

CRIS 1.309

-10.3%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Norton who started this subject	1/16/2004 3:51:13 PM
From: Bird	Read Replies (1) of 668

CRIS target raised to $9 @14.43 finance.yahoo.com 14:43 ET CRIS target raised to $9 at Stephens 6.05 +0.20: Stephens raises their target on Curis to $9 from $8 following Monday's announcement that the co signed a drug development partnership with Wyeth; firm says the financial benefits to CRIS before royalty payments could total more than $170 mln if at least two molecules that activate the Hh pathway are successfully developed by WYE; also, firm notes that with this deal, CRIS has partnerships with significant rev opportunities with Wyeth, Genentech, and Johnson & Johnson (JNJ), all co's that they consider in the top tier of biotech and pharma co's.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next